Form 4: Fulgent Genetics CEO Ming Hsieh Reports Stock Transaction
SEC Form 4
Fulgent Genetics CEO Ming Hsieh reports disposition of shares to cover tax obligations and details beneficial ownership through trusts and minor accounts.
Summary
- On May 1, 2025, Ming Hsieh, the CEO of Fulgent Genetics, disposed of 1,339 shares of common stock at a price of $17.25 per share to satisfy tax withholding obligations.
- Following the transaction, Mr. Hsieh directly owns 815,739 shares.
- Mr. Hsieh also has indirect ownership through the Dynasty Trust (220,816 shares), The Ming Hsieh Trust (7,895,115 shares), and Uniform Transfer to Minor Accounts (2,000 shares).
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing a routine stock transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives and significant shareholders.
Key Dates
| Date | Description |
|---|---|
| 08/01/2022 | Date of restricted stock units grant to the reporting person. |
| 08/03/2022 | Form 4 filed with the U.S. Securities and Exchange Commission reporting the restricted stock units grant. |
| 05/01/2025 | Date of stock transaction (disposal of shares). |
| 05/05/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Beneficial Ownership, Stock Transaction, Ming Hsieh, Fulgent Genetics, FLGT, CEO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.